Metabolic Eye Diseases: From Tomography to Clinical Prediction
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Physiology and Pathology".
Deadline for manuscript submissions: 31 October 2025 | Viewed by 80
Special Issue Editors
Interests: retina; visual fields; retinal degeneration; macular degeneration; photoreceptor cells; optical coherence tomography
2. Department of Ophthalmology, Cochin Hospital, Université Paris-Cité, Assistance Publique–Hôpitaux de Paris, Paris, France
Interests: ophthalmology and eye diseases; cornea, cataract, and refractive surgery; ocular surface disorders and corneal pathologies; optical coherence tomography (OCT) in eye diseases; metabolic eye diseases; artificial intelligence in ophthalmology; clinical and translational ophthalmic research
Special Issue Information
Dear Colleagues,
Metabolic eye diseases encompass a broad spectrum of disorders in which metabolic dysfunctions play a critical role in ocular pathology. Recent advancements in imaging technologies, such as optical coherence tomography (OCT), fundus autofluorescence, and metabolic imaging, have revolutionized our understanding of these conditions. This Special Issue aims to explore the intricate relationship between metabolic pathways and ocular health, shedding light on how metabolic dysregulation contributes to disease onset, progression, and clinical outcomes.
We invite researchers to contribute original studies and reviews focusing on novel diagnostic approaches, imaging biomarkers, artificial intelligence-driven predictive models, as well as translational insights into metabolic eye diseases. Topics of interest include, but are not limited to, diabetic retinopathy, mitochondrial optic neuropathies, metabolic-related macular degeneration, inherited metabolic disorders affecting vision, and corneal manifestations of metabolic diseases. Corneal involvement in metabolic disorders, such as cystinosis, mucopolysaccharidoses, and Schnyder corneal dystrophy, highlights the diverse ways in which metabolic dysfunctions can impact ocular structures. By integrating cutting-edge tomography techniques with clinical prediction models, this Special Issue seeks to bridge the gap between fundamental research and real-world clinical applications.
We welcome interdisciplinary perspectives from ophthalmology, neurology, endocrinology, biomedical engineering, etc., to foster a deeper understanding of these complex disorders. We look forward to your valuable contributions that will enhance both diagnostic precision and therapeutic strategies in metabolic eye diseases.
Dr. Akio Oishi
Dr. Nilufer Yesilirmak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- metabolic eye diseases
- ophthalmic tomography and imaging biomarkers
- diabetic retinopathy and systemic metabolic disorders
- mitochondrial dysfunction and optic neuropathies
- corneal metabolic diseases and ocular surface disorders
- artificial intelligence in clinical prediction of eye diseases
- metabolic pathways and retinal degeneration
- translational research in metabolic ophthalmology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
